Posted On: 09/03/2014 3:18:12 AM
Post# of 273350
Digipath (DIGP) 0.7940 $DIGP
DigiPath, Inc., Completes Management Restructuring with Three Senior Appointments
PR Newswire - Mon Aug 25, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and other services to the cannabis industry, announced three top-level appointments today, completing its management restructuring plan.
Global Digital Pathology Market 2014-2018 - Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage
M2 - Tue Aug 19, 5:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ggtzl3/digital_pathology) has announced the addition of the "Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Global Forecasts & Trends to 2018" report to their offering. This report categorizes the global digital pathology market into different products and applications. Scanners accounted for the largest share of the digital pathology products market, followed by analytics. The analytics market is expected to grow at the highest CAGR of 12.4% from 2013 to 2018. The high growth can be attributed to the growing importance of image analysis software that is increasingly being used to understand cancer complexity and the drive for personalized medicine, among others. This report covers the definition, description, and forecast of the global market in terms of products, applications, and geographies. The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The dominance of the North American market can be attributed to reasons such as the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, the Asian market is expected to experience the highest growth in the market. The high growth in the Asian region can be attributed to the rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the uses to improve the quality of cancer diagnosis. Some of the prominent players in the global market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Digital Pathology: Rationale for Adoption 5 Global Digital Pathology Market, By Product 6 Global Digital Pathology Market, By Application 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - 3dhistech Ltd. - Apollo Pacs, Inc. - Aurora Interactive Ltd. - Corista LLC - Definiens AG - Digipath, Inc. - Hamamatsu Photonics K.K. - Huron Technologies International, Inc. - Indica Labs, Inc. - Kanteron Systems - Leica Biosystems, Gmbh - Ligolab, LLC - Mikroscan Technologies, Inc. - Nikon Instruments, Inc. - Objective Pathology Services, Ltd. - Omnyx, LLC - Pathxl, Ltd. - Pixcelldata, Ltd. - Sunquest Information Systems, Inc. - Ventana Medical Systems, Inc. - Visiopharm - Xifin, Inc. For more information visit http://www.researchandmarkets.com/research/gg..._pathology
DigiPath's Dr. Cindy Orser Speaks on the Importance of Adopting Cannabis Standards August 14, 2014
PR Newswire - Tue Aug 05, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into the cannabis testing and education markets, announced today that Cindy Orser, Ph.D. will lead an introductory webinar on the importance of standards in the cannabis industry on Thursday, August 14, 2014. The key issue of adopting standards is the second in a five-week series of webinars collectively titled: "Cannabis 2.0: Making It in the Emerging Marijuana Industry," which begins on August 7th.
DigiPath No New Corporate Developments
PR Newswire - Wed Jul 30, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and affairs not previously disclosed or, to its knowledge, any other reason to account for the recent unusual market action.
OTC Trading Stock News: Digipath, Inc. Immune Pharmaceuticals, Inc. Vuzix Corp, Nuvilex, Inc. Origin Oil, Inc.
PR Newswire Europe - Tue Jul 29, 7:07AM CDT
LONDON, July 29, 2014 /PRNewswire/ --
Cannabis Stocks Moved Lower Last Week, but Novus & Terra Tech Were Smokin'
ACCESSWIRE - Mon Jul 28, 8:33AM CDT
WHITEFISH, MT / July 28, 2014 / The Marijuana Index(TM) moved lower last week after a modest 1.6% rise in bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) was offset by a significant 4.9% drop in MedBox Inc. (OTC: MDBX) shares.
DigiPath Raises $8.2 Million to Expand into Cannabis Industry
ACCESSWIRE - Fri Jul 25, 8:41AM CDT
WHITEFISH, MT / July 25, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research. So far, 23 U.S. states and Washington D.C. have legalized medical marijuana, while Colorado and Washington State have legalized recreational marijuana. These trends are poised to continue in the November general election with several outstanding ballot measures in place.
DigiPath Raises $8.2 Million to Expand into Cannabis Testing and Education, Files 10-Q
PR Newswire - Wed Jul 23, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced the filing of its periodic report on Form 10-Q for the quarter ended June 30, 2014, which disclosed the consummation of financings in the aggregate amount of $8.2 million from accredited investors during its third fiscal quarter.
Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia
ACCESSWIRE - Tue Jul 22, 8:32AM CDT
WHITEFISH, MT / July 22, 2014 / The Marijuana Index(TM) moved slightly higher last week, despite a 7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Medbox Inc. (OTC: MDBX), the second largest component of the index, also fell over 5% last week.
Capitalizing on the Green Rush in the Burgeoning Marijuana Industry
ACCESSWIRE - Fri Jul 18, 12:10PM CDT
Whitefish, MT / July 18, 2014 / In April 2014, Marijuana Business Daily forecast that US retail cannabis sales will rise from an estimated $2.2-$2.6 billion in 2014 to $7.4-8.2 billion in 2018. Recreational marijuana sales comprise the bulk of the increase, but medicinal use is expected to more than double as well--up to $4 billion in the next five years.
The National Marijuana News: DigiPath Enables Balanced Cannabis News Reporting
PR Newswire - Wed Jul 16, 4:30PM CDT
DigiPath, Inc. (OTCQB: DIGP / "DigiPath"
, a digital laboratory provider within the human, animal, and cannabis testing markets, announces the launch of The National Marijuana News ("TNMNews" . The balanced cannabis news site and talk radio show focus on the political, economic, medicinal, and cultural dimensions of the rapidly evolving--and profoundly controversial--medicinal and recreational marijuana industry.
Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
DigiPath Launches Vocational Cannabis Education and Training Division
PR Newswire - Tue Jul 01, 7:45AM CDT
Digital pathology solutions provider DigiPath, Inc. (OTCQB: DIGP / "DigiPath" has announced the launch of its new cannabis education and training division to support its line of service expansion to include cannabis testing and education.
DigiPath Secures Permit to Open Nevada Cannabis Testing Labs in Clark County
PR Newswire - Mon Jun 23, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a life sciences company that creates digital pathology solutions, and is entering into the botanical nutraceutical industry has just received the approval from the Clark County Commission to operate a botanical nutraceutical and cannabis testing laboratory in Las Vegas, Nevada. DigiPath Labs is hoping for final approval by the State of Nevada within the next few months.
DigiPath Next Generation Pathology Solutions
ACCESSWIRE - Thu Aug 08, 9:00AM CDT
The healthcare industry has become increasingly digitized over the past decade, with companies like Cerner Corporation (NASDAQ: CERN) and MedAssets Inc. (NASDAQ: MDAS) bringing an age-old industry up-to-speed with modern technology. But, patient medical records represent only a fraction of the digital revolution and one sector has been slower than others to modernize.
Digital Pathology Systems - Global Strategic Business Report - 2013-2018
M2 - Wed May 08, 4:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t9h3l3/digital_pathology) has announced the addition of the "Digital Pathology Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 46 companies including many key and niche players such as 3DHISTECH Ltd., AccelPath, Inc., Apollo PACS, Inc., Carl Zeiss MicroImaging GmbH, Corista LLC, Definiens AG, DigiPath Inc., Flagship Biosciences, LLC, Koninklijke Philips Electronics N.V., Leica Microsystems GmbH, Aperio Technologies, Inc., MikroScan Technologies, Inc., Olympus America, Inc., Omnyx, LLC, Pixcelldata Ltd., Ventana Medical Systems, Inc., BioImagene, Inc., a
DigiPath, Inc., Completes Management Restructuring with Three Senior Appointments
PR Newswire - Mon Aug 25, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and other services to the cannabis industry, announced three top-level appointments today, completing its management restructuring plan.
Global Digital Pathology Market 2014-2018 - Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage
M2 - Tue Aug 19, 5:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ggtzl3/digital_pathology) has announced the addition of the "Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Global Forecasts & Trends to 2018" report to their offering. This report categorizes the global digital pathology market into different products and applications. Scanners accounted for the largest share of the digital pathology products market, followed by analytics. The analytics market is expected to grow at the highest CAGR of 12.4% from 2013 to 2018. The high growth can be attributed to the growing importance of image analysis software that is increasingly being used to understand cancer complexity and the drive for personalized medicine, among others. This report covers the definition, description, and forecast of the global market in terms of products, applications, and geographies. The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The dominance of the North American market can be attributed to reasons such as the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, the Asian market is expected to experience the highest growth in the market. The high growth in the Asian region can be attributed to the rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the uses to improve the quality of cancer diagnosis. Some of the prominent players in the global market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Digital Pathology: Rationale for Adoption 5 Global Digital Pathology Market, By Product 6 Global Digital Pathology Market, By Application 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - 3dhistech Ltd. - Apollo Pacs, Inc. - Aurora Interactive Ltd. - Corista LLC - Definiens AG - Digipath, Inc. - Hamamatsu Photonics K.K. - Huron Technologies International, Inc. - Indica Labs, Inc. - Kanteron Systems - Leica Biosystems, Gmbh - Ligolab, LLC - Mikroscan Technologies, Inc. - Nikon Instruments, Inc. - Objective Pathology Services, Ltd. - Omnyx, LLC - Pathxl, Ltd. - Pixcelldata, Ltd. - Sunquest Information Systems, Inc. - Ventana Medical Systems, Inc. - Visiopharm - Xifin, Inc. For more information visit http://www.researchandmarkets.com/research/gg..._pathology
DigiPath's Dr. Cindy Orser Speaks on the Importance of Adopting Cannabis Standards August 14, 2014
PR Newswire - Tue Aug 05, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into the cannabis testing and education markets, announced today that Cindy Orser, Ph.D. will lead an introductory webinar on the importance of standards in the cannabis industry on Thursday, August 14, 2014. The key issue of adopting standards is the second in a five-week series of webinars collectively titled: "Cannabis 2.0: Making It in the Emerging Marijuana Industry," which begins on August 7th.
DigiPath No New Corporate Developments
PR Newswire - Wed Jul 30, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and affairs not previously disclosed or, to its knowledge, any other reason to account for the recent unusual market action.
OTC Trading Stock News: Digipath, Inc. Immune Pharmaceuticals, Inc. Vuzix Corp, Nuvilex, Inc. Origin Oil, Inc.
PR Newswire Europe - Tue Jul 29, 7:07AM CDT
LONDON, July 29, 2014 /PRNewswire/ --
Cannabis Stocks Moved Lower Last Week, but Novus & Terra Tech Were Smokin'
ACCESSWIRE - Mon Jul 28, 8:33AM CDT
WHITEFISH, MT / July 28, 2014 / The Marijuana Index(TM) moved lower last week after a modest 1.6% rise in bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) was offset by a significant 4.9% drop in MedBox Inc. (OTC: MDBX) shares.
DigiPath Raises $8.2 Million to Expand into Cannabis Industry
ACCESSWIRE - Fri Jul 25, 8:41AM CDT
WHITEFISH, MT / July 25, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research. So far, 23 U.S. states and Washington D.C. have legalized medical marijuana, while Colorado and Washington State have legalized recreational marijuana. These trends are poised to continue in the November general election with several outstanding ballot measures in place.
DigiPath Raises $8.2 Million to Expand into Cannabis Testing and Education, Files 10-Q
PR Newswire - Wed Jul 23, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced the filing of its periodic report on Form 10-Q for the quarter ended June 30, 2014, which disclosed the consummation of financings in the aggregate amount of $8.2 million from accredited investors during its third fiscal quarter.
Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia
ACCESSWIRE - Tue Jul 22, 8:32AM CDT
WHITEFISH, MT / July 22, 2014 / The Marijuana Index(TM) moved slightly higher last week, despite a 7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Medbox Inc. (OTC: MDBX), the second largest component of the index, also fell over 5% last week.
Capitalizing on the Green Rush in the Burgeoning Marijuana Industry
ACCESSWIRE - Fri Jul 18, 12:10PM CDT
Whitefish, MT / July 18, 2014 / In April 2014, Marijuana Business Daily forecast that US retail cannabis sales will rise from an estimated $2.2-$2.6 billion in 2014 to $7.4-8.2 billion in 2018. Recreational marijuana sales comprise the bulk of the increase, but medicinal use is expected to more than double as well--up to $4 billion in the next five years.
The National Marijuana News: DigiPath Enables Balanced Cannabis News Reporting
PR Newswire - Wed Jul 16, 4:30PM CDT
DigiPath, Inc. (OTCQB: DIGP / "DigiPath"
, a digital laboratory provider within the human, animal, and cannabis testing markets, announces the launch of The National Marijuana News ("TNMNews" . The balanced cannabis news site and talk radio show focus on the political, economic, medicinal, and cultural dimensions of the rapidly evolving--and profoundly controversial--medicinal and recreational marijuana industry. Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.
Cannabis Sativa & Easton Pharmaceuticals Led Cannabis Stocks Higher Last Week
ACCESSWIRE - Tue Jul 08, 8:07AM CDT
Whitefish, MT / July 8, 2014 / The Marijuana Index(tm) was mixed last week, as index heavyweights GW Pharmaceuticals plc (NASDAQ: GWPH) and Medbox Inc. (OTC: MDBX) gave up some of their earlier gains towards the end of the week.
DigiPath Launches Vocational Cannabis Education and Training Division
PR Newswire - Tue Jul 01, 7:45AM CDT
Digital pathology solutions provider DigiPath, Inc. (OTCQB: DIGP / "DigiPath"
has announced the launch of its new cannabis education and training division to support its line of service expansion to include cannabis testing and education. DigiPath Secures Permit to Open Nevada Cannabis Testing Labs in Clark County
PR Newswire - Mon Jun 23, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a life sciences company that creates digital pathology solutions, and is entering into the botanical nutraceutical industry has just received the approval from the Clark County Commission to operate a botanical nutraceutical and cannabis testing laboratory in Las Vegas, Nevada. DigiPath Labs is hoping for final approval by the State of Nevada within the next few months.
DigiPath Next Generation Pathology Solutions
ACCESSWIRE - Thu Aug 08, 9:00AM CDT
The healthcare industry has become increasingly digitized over the past decade, with companies like Cerner Corporation (NASDAQ: CERN) and MedAssets Inc. (NASDAQ: MDAS) bringing an age-old industry up-to-speed with modern technology. But, patient medical records represent only a fraction of the digital revolution and one sector has been slower than others to modernize.
Digital Pathology Systems - Global Strategic Business Report - 2013-2018
M2 - Wed May 08, 4:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t9h3l3/digital_pathology) has announced the addition of the "Digital Pathology Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 46 companies including many key and niche players such as 3DHISTECH Ltd., AccelPath, Inc., Apollo PACS, Inc., Carl Zeiss MicroImaging GmbH, Corista LLC, Definiens AG, DigiPath Inc., Flagship Biosciences, LLC, Koninklijke Philips Electronics N.V., Leica Microsystems GmbH, Aperio Technologies, Inc., MikroScan Technologies, Inc., Olympus America, Inc., Omnyx, LLC, Pixcelldata Ltd., Ventana Medical Systems, Inc., BioImagene, Inc., a
(0)
(0)
